Abstract:This research aimed to evaluate whether maternal dietary n-3 polyunsaturated fatty acids (PUFA) supplementation could decrease placental lipid deposition and improve placental antioxidant capacity through a SIRT1-dependent way. In the present study, male and female SIRT1+/- mice were mated overnight, then primiparous SIRT1+/- mice were fed a 60% kcal high-fat-diet (HFD) or equienergy EPA diet (4.4% EPA-ethyl ester) (n = 22/each group). At pregnant 18.5 d, retro-orbital blood samples were obtained then sacrificed by cervical dislocation. Placentas and its corresponding fetuses were collected by caesarean section. We found that the EPA diet significantly changed maternal plasma, placenta and fetus fatty acid composition, and decreased placental and fetal lipid content. Meanwhile, EPA treatment significantly increased placental and fetal antioxidant capacity, however, lipid peroxidation products malondialdehyde was also increased. Moreover, EPA treatment significantly activated placental UCP1 and PGC1α expression and alleviated mitochondrial swelling induced by HFD. SIRT1 knockout had no significant effect on placental lipid content, but notably decreased fetal triglyceride (TG) and non-esterified fatty acid (NEFA) content. Meanwhile, SIRT1 knockout significantly decreased the ratio of n-3 PUFA in placenta. SIRT1 knockout also significantly decreased PGC1α mRNA and protein level and increased mitochondrial swelling. Both EPA treatment and SIRT1 deficiency had no effect on BODIPY-FL-C16 (a fluorescent labeled palmitic acid) uptake in placenta and fetus. No significant effect was observed between diet and genotype. In conclusion, our study demonstrated that maternal EPA feeding decreased placental and fetal lipid deposition and improved antioxidant capacity through a Sirtuin-1 independent mechanism.

PSXIII-3 Maternal Eicosapentaenoic Acid Feeding Decreases Placental and Fetal Lipid Deposition and Improves Antioxidant Capacity Through a Sirtuin-1 Independent